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Abstract
Background: diabetes is a serious health problem and a source of risk for numerous severe complications such as
obesity and hypertension. Treatment of diabetes and its related diseases can be achieved by inhibiting key
digestives enzymes-related to starch digestion secreted by pancreas.
Methods: The formulation omega-3 with fenugreek terpenenes was administrated to surviving diabetic rats. The
inhibitory effects of this oil on rat pancreas a-amylase and maltase and plasma angiotensin-converting enzyme
(ACE) were determined.
Results: the findings revealed that administration of formulation omega-3 with fenugreek terpenenes (Om3/terp)
considerably inhibited key enzymes-related to diabetes such as a-amylase activity by 46 and 52% and maltase
activity by 37 and 35% respectively in pancreas and plasma. Moreover, the findings revealed that this supplement
helped protect the b-Cells of the rats from death and damage. Interestingly, the formulation Om3/terp modulated
key enzyme related to hypertension such as ACE by 37% in plasma and kidney. Moreover administration of
fenugreek essential oil to surviving diabetic rats improved starch and glucose oral tolerance additively.
Furthermore, the Om3/terp also decreased significantly the glucose, triglyceride (TG) and total-cholesterol (TC) and
LDL-cholesterol (LDL-C) rates in the plasma and liver of diabetic rats and increased the HDL-Cholesterol (HDL-Ch)
level, which helped maintain the homeostasis of blood lipid.
Conclusion: overall, the findings of the current study indicate that this formulation Om3/terp exhibit attractive
properties and can, therefore, be considered for future application in the development of anti-diabetic, anti-
hypertensive and hypolipidemic foods.
Background
Diabetes mellitus is a major and growing public health
problem throughout the world, with an estimated world-
wide prevalence in 2008 more than of 347 million peo-
ple and is a heterogeneous disorder with varying
prevalence among different ethnic groups and it is
reported to constitute the 16th leading cause of global
mortality [1,2]. It is generally recognized that patients
with diabetes are at risk for numerous severe
complications, including diabetic obesity, hyperlipidemia
and hypertension [3-5]. In this respect, many synthetic
a-amylase and maltase inhibitors have been reported to
reduce plasma glucose and lipid levels via delaying glu-
cose absorption and retarding the liberation of glucose
from oligosaccharides and disaccharides from dietary
complex carbohydrates [6]. Nevertheless, the use of
these inhibitors often induced disturbances in the gas-
trointestinal tract, including flatulence, diarrhea, and
abdominal pain [6]. Accordingly, recent research seems
to have granted special interest for the search of effec-
tive natural a-amylase and ACE inhibitors. In the same
vein, essential oil isolated from plant sources, have
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arena particularly for their broad spectrum of therapeu-
tic properties and relatively low toxicity [7,8]. Numerous
studies have confirmed that consumption of omega-3
reduces the risk of developing chronic diseases such as
diabetes and heart disease [9-11]. The benefits of
omega-3 include anti-inflammatory and anti-oxidant
effects[11]. Trigonella foenumgraecum has been shown
to possess hypoglycaemic, anti-hypertensive and hypoli-
pidemic activities in experimental animals as in human
[9]. Fenugreek essential oil from the seeds of the trigo-
nella foenum gracecum plant is rich in terpenenes.
These nutrients, along with antioxidants, endow fenu-
greek essential oil with the power to fight viruses, cancer
tumors, and free radicals which lead to aging. Recent
studies have found that terpenenes can be absorbed
through the gut and plays an important role in the con-
trol of cholesterol metabolism [12-14]. However, very
little is known about cellular and biochemical mechan-
ism of the anti-hyperglycemic and anti-hypertensive
effect of fenugreek. Therefore, this study was undertaken
to assess the effect of dietary fenugreek essential oil on
key enzymes related to diabetes and hypertension, pan-
creas architecture and lipid profile in surviving diabetic
rats.
Materials and methods
Extraction of terpenenes from fenugreek oil
The Fresh fenugreek seeds, purchased from a local mar-
ket located at Sfax, Tunisia, were completely immersed
in water and hydro-distilled for 4 hours in a Clevenger-
type apparatus giving greenish-yellow oil. When the
condensed material cooled down, the water and essen-
tial oils were separated. The oil was decanted to be used
as essential oil. To improve its recovery, the essential oil
was taken up in diethyl ether, dried over anhydrous
sodium sulphate until the last traces of water were
removed and stored in a dark glass bottle at 4°C until
tested and analyzed. The extraction yield was 1.24% (w/
w). To improve their quality, we add of this oil 15% of
commercial omega 3 according of Pharmacy Central
industry, Sfax, Tunisia).
Gas chromatography-mass spectrometry (GC-MS)
The analysis of the fenugreek essential oil was per-
formed on a GC-MS HP model 5975B inert MSD (Agi-
lent Technologies, J&W Scientific Products, Palo Alto,
CA, USA), equipped with an Agilent Technologies capil-
lary DB-5MS column (30 m length; 0.25 mm i.d.; 0.25
mm film thickness), and coupled to a mass selective
detector (MSD5975B, ionization voltage 70 eV; all Agi-
lent, Santa Clara, CA). The carrier gas was He and was
used at 1 mL min
-1 flow rate. The oven temperature
program was as follows: 1 min at 100°C ramped from
100 to 260°C at 4°C min
-1 and 10 min at 260°C. The
chromatograph was equipped with a split/splitless injec-
tor used in the split mode. The split ratio was 1:100.
Identification of components was assigned by matching
their mass spectra with Wiley and NIST library data,
standards of the main components and comparing their
Kovats Retention Indices (KRI) with reference libraries
[15,16] and from the literature. The component concen-
tration was obtained by semi-quantification by peak area
integration from GC peaks and by applying the correc-
tion factors.
Total n-3 fatty acids were analyzed by gas chromato-
graphy as described previously [15,16] using a 28 com-
ponent quantitative standard mixture (Prep 462; Nu-
Chek Prep).
Experimental induction of diabetes
Adult male Wistar rats, weighing 179 ± 10 g, and
obtained from the Central Pharmacy, Tunisia, were
employed in the study. The animals were kept in an
environmentally controlled breeding room (temperature:
20 ± 2°C, humidity: 60 ± 5%, 12-hr dark/light cycle). All
rats had free access to tap water and fasted overnight
before blood and tissue collection. Diabetes was
induced in rats by a single intraperitoneal injection of
freshly prepared alloxan solution in normal saline at a
dose of 150 mg/kg body weight [5]. The rats were then
kept for the next 24 hr on 5% glucose solution bottles
in their cages to prevent hypoglycemia. After 2 weeks,
rats with moderate diabetes having glycosuria and
hyperglycemia (i.e., with blood glucose levels of 2 g/L)
were chosen for the experiment. The handling of the
animals was approved by the Tunisian Ethical Commit-
tee for the care and use of laboratory animals.
Experimental procedure
A total of 60 rats (50 diabetic surviving rats and 10 con-
trol animals) were used. For diabetic rats, 1 month after
alloxan injection and diabetes apparition, the day of
beginning of experiments, 10 diabetic were sacrificed
and referred as a diabetic rats before treatment (group
1) [(Diab(day0)] (glycemia 2 g/L). The other diabetic
rats were divided into 5 groups: group 2, diabetic con-
trol rats named diabetic rats after treatment [Diab(day
60)]; group 3, diabetic rats treated with formulation:
Omega-3 Fatty Acid Rich Fenugreek Essential Oil (5%
in food) [Diab+For] [17]; group 4, diabetic rats treated
with Fenugreek Essential Oil at a dose of 5% in food
named [FO]; group 5, diabetic rats treated with omega 3
at a dose of 5% in food named [Om3] ]and group 6:
normal rats were used as controls [Con]. Eight weeks
after the beginning of oils administration to diabetic
rats, the animals were sacrificed by decapitation, and the
trunk blood collected. The serum was prepared by
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Page 2 of 10centrifugation (1,500 × g, 15 min, 4°C) the liver was
removed, cleaned of fat; all these samples were stored at
-80°C until used.
Biochemical analysis
Alloxan, maltose, sucrose, and lactose were purchased
f r o mS i g m a - A l d r i c h( S t .L o u i s ,M O ,U S A ) ,t h eG O D ,
HDL, TC, TG and a-amylase kits were from Biomagh-
reb analyticals (Tunis, Tunisia). All other chemicals
used were of analytical grade. The pancreas of each rat
was excise. The pancreas was then homogenized and
centrifuged (5,000 × g, 20 min). The supernatant was
frozen and stored for further use in subsequent enzy-
matic assays. The activities of pancreas a-amylase and
maltase activities were obtained by measuring the
amount of glucose released from various substrates
[18,19]. The plasma and kidney Serum ACE activity was
measured using Hippuryl-His-Leu (HHL) as a synthetic
substrate. For oral glucose and starch tolerance test, the
carbohydrates loaded were as follows: glucose (2 g/kg)
and starch (1 g/kg. These carbohydrates were orally
administered via a gastric gavage route. Blood samples
were collected from the tail vein at 0, 0.5, 1, and 2 h
after the carbohydrate and oil administration. Total-cho-
lesterol, triglyceride, albumin and HDL-cholesterol in
the serum were measured using commercial kits from
Biomagreb (Tunis, Tunisia). The level of total protein
was determined by the method of Lowry et al using
bovine serum albumin as the standard at 660 nm [20].
For histological studies, pieces of pancreas were fixed in
a Bouin solution for 24 hours, and then embedded in
paraffin. Sections of 5-μm thickness were stained with
hematoxylin-eosin and examined under an Olympus
CX41 light microscope.
Statistical analysis
The data are presented as means ± SD. The determina-
tions were performed from eight animals per group and
the differences were examined by the one-way analysis
of variance followed by the Fisher test (Stat View). Sta-
tistical significance was accepted at p < 0.05.
Results
Essential oil analysis
The chemical composition of fenugreek essential oil is
presented in Table 1. The average yield in essential oil
was 1.24% (w/w). GC-MS analysis resulted in the identi-
fication of 13 compounds representing 97.2% of the
total essential oil. The most abundant components (>
4%) of the fenugreek essential oil were b-pinene
(15.05%), 2,5-dimethylpyrazine (6.14%), 6-methyl-5-hep-
ten-2-one (4.48%), camphor (16.32%), 3-octen-2-one
(4.32%), b-caryophyllene (14.63%), neryl acetate
(17.32%), a-selinene (4.04%) and geranial (4.81%). The
identified compounds are known and were reported in a
previous study (Table 1).
Effect of the formulation Om3/terp on a-amylase activity
in plasma and pancreas and blood glucose level of
control and diabetic rats
The findings indicated that compared to the control,
there was a significant increase in the activities of a-
amylase and maltase in pancreas and plasma of diabetic
rats, which leads to significant increase in plasma glu-
cose rate by 259%. However, the administration of the
formulation Om3/terp to surviving diabetic rats is asso-
ciated by considerable reductions in the plasma and
pancreas a-amylase and maltase activities. This potential
inhibitory effect of the formulation Om3/terp on a-amy-
lase and maltase activities in both plasma and pancreas
was confirmed by a reduction of blood glucose rate by
51% (Figure 1 &2).
Effect of the formulation Om3/terp on oral carbohydrate
tolerance test (OCTT) in diabetic rats
With the intent to assess the effect of orally adminis-
tered the formulation Om3/terp on systemic glucose
homeostasis and confirmed the potential inhibitory
action of key digestive enzymes on carbohydrate diges-
tion secreted by pancreas, we performed an oral glucose
and Starch tolerance test in conscious fasted rats after
the formulation Om3/terp administration. These results
clearly showed that, acute oral administration of the for-
mulation Om3/terp reduced significantly peak glucose
concentration 60 min after glucose and starch adminis-
tration as compared to untreated diabetic rats (Figure 2).
Effect of the formulation Om3/terp on plasma and liver
total n-3 fatty acids concentration
Figure 3 indicates that, when compared to the non-dia-
betic rats, the total n-3 fatty acids concentrations in
plasma and liver decreased significantly in the diabetic
rats. Interestingly, in diabetic rats, the administration of
the formulation Om3/terp greatly increased the total n-
3 fatty acids levels in both plasma and liver (Figure 3).
Effect of the formulation Om3/terp on plasma and liver
lipid concentration
Figure 5 indicates that hyperglycaemia associated by
remarkable increases in the total-cholesterol, triglyceride
and LDL-cholesterol concentrations in the plasma and
liver and decrease in the HDL-cholesterol compared to
that of the non-diabetic rats (Table 2). However, the
administration of the formulation Om3/terp to surviving
diabetic rats was reverted back the rate of the total-cho-
lesterol, triglycerides and LDL-cholesterol in the plasma
and liver. Moreover, fenugreek omega-3 fatty acid rich
fenugreek essential oil supplement to surviving diabetic
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liver of diabetic rats.
Effect of the formulation Om3/terp on pancreas
architecture
The data indicated that compared to the case of the
control rats, alloxan exhibited b-Cells degeneration in
the pancreas of diabetic. A potent protective action of
b-Cells was, however, recorded in the diabetic rats trea-
ted with the formulation Om3/terp (Figure 4).
Effect omega-3 fatty acid rich fenugreek essential oil on
plasma ACE activity
Figure 5 indicates that the plasma ACE activity in the
diabetic rats underwent a potent increase of 45% as
compared to the non-diabetic rats. However, the admin-
istration of the formulation Om3/terp to surviving dia-
betic rats was reverted back the activity of ACE in
plasma back by 38%.
Discussion
Dietary carbohydrate in human is a major nutrient and
a-amylase play an important role in carbohydrate diges-
tion. It is generally recognized that carbohydrates are
digested into oligosaccharides by a-amylase and then
into maltose by enzymes secreted by the digestive tract.
Maltose is then converted into glucose by maltase
located in the small intestinal mucosa [21-23]. It was
reported that many a-amylase inhibitors may reduce
postprandial plasma glucose level via retarding the lib-
eration of D-glucose of oligosaccharides and disacchar-
ides from dietary complex carbohydrates and delaying
glucose absorption. However, usefulness of these a-amy-
lase inhibitors often induced disturbances of the gastro-
intestinal tract, including flatulence, diarrhea, and
abdominal pain [24].
Many studies have shown effects of different dietary
constituents on a-amylase and maltase activity during
diabetes. Dietary spices or their active principles have
been shown to have a positive influence on activities of
disaccharidases. Our studies have shown a significant
improvement in pancreas and plasma a-amylase and
maltase activity in fenugreek essential oil-fed diabetic
groups when compared to untreated-diabetic groups. In
this study, a highest level obtained in the fenugreek
essential oil is Neryl acetate (17%), Camphor (16%) and
b-Pinene (15%). The terpenes such as b-pinene which
exist in fenugreek essential oil inhibited key enzymes
related to type 2 diabetes principally a-amylase and mal-
tase in both pancreas and plasma and consequently
hyperglycemia (Figure 1, 2). In fact, recent research has
reported that administration of terpenenes to diabetic
exert blood glucose lowering effect and high antioxidant
activity in alloxan-induced diabetic rat [12-15]. There-
fore, minimally processed and phytochemical enriched
plants such as vegetables, fruits, nuts, seeds, and grains
generally increase postprandial glucose and triglycerides
to a lesser degree than do processed foods [12-15].
Moreover, this study showed that administration of
fenugreek essential oil to surviving diabetic rats restores
the structure of pancreas bcells resulting in the increase
of insulin secretion which decreases glucose level in
plasma. Both the inhibitory effect of key enzymes related
to starch digestion and absorption of starch and the
Table 1 Chemical composition of fenugreek essential oil.
No. Compound Composition (%) Retention time (min) KRI
1 b-Pinene 15.05 6.99 1023
2 2,5-Dimethylpyrazine 6.14 7.78 1103
3 6-Methyl-5-hepten-2-one 4.48 8.29 1206
4 a-Pinene 2.61 8.54 1109
5 g-Terpinene 2.08 8.58 1251
6 Camphor 16.32 8.66 1514
7 3-Octen-2-one 4.32 8.87 1538
8 a-Campholenal 2.63 8.89 1471
9 b-Caryophyllene 14.63 8.92 1679
10 a-Terpineol 2.77 9.34 1677
11 Neryl acetate 17.32 9.56 1828
12 a-Selinene 4.04 9.89 1738
13 Geranial 4.81 9.99 1579
Identification components (%) 97.2
Yield (%) (w/fw) 1.24
Omega 3 (18:3) 15% of total oil
No: Numbers correspond to the peaks observed in the GC-MS chromatogram. KRI: Kovats Retention Index, retention index relative to n-alcane on DB-5MS
Capillary column. w/fw: weight/fresh weight.
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essential oil prevent the increase of blood level as anti-
diabetic action. Others studies have reported that
administration of herbal terpenes such as b-pinene,
existed in fenugreek oil (Table 1) to surviving diabetic
rats protect the architecture of pancreas b-cells, preserve
the insulin secretion and stimulate the regeneration of
this type of cells [22,23].
Additionally, this study showed that administration of
formulation Om3/terp to surviving diabetic rats was
associated by lower level of TG and total-cholesterol
and higher rate of HDL-cholesterol in plasma of diabetic
rats [22,23]. Diabetic rats treated with omega-3 fatty
acid rich fenugreek essential oil show a therapeutic
action. In fact, a significant decrease in TCh and TG
content and increase in HDL-Ch rate were observed in
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Figure 1 Inhibitory effect of formulation Om3/terp on a-amylase and maltase activities in pancreas and plasma and blood glucose
rate on surviving diabetic rats. Values are given as mean ± SD for group of 10 animals each. Values a re statistically presented as follows: *P
< 0.05 significant differences compared to controls.
#P < 0.05 significant differences compared to diabetic rats day0.
@P < 0.05 significant
differences compared to diabetic rats day60. δp < 0.05 significant differences compared to diabetic rats treated with omega-3 fatty acid rich
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εP < 0.05 significant differences compared to diabetic rats treated with FO.
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Page 5 of 10both plasma and hepatic tissues. This hypolipidemic and
hypercholesterolemia effect of formulation Om3/terp
probably resulted to omega 3, which exert potential
hypolipidemic activity by their capacity[24] to i) inhibi-
tion of key enzyme related to cholesterol synthesis and
transfer such as 3-Hydroxy-3-methylglutaryl (HMG)-
CoA reductase and acyl-CoA:cholesterol acyltransferase
(ACAT) activities [25] ii) theirs role in the control of
peroxisome proliferator-activated receptor a (PPAR-a)
that controls the expression of genes involved in hepatic
fatty acid oxidation and the transcription factor
SREBP1c that is required for suppression of de novo
lipogenesis and monounsaturated fatty acids synthesis
[26] iii) inhibition of intestinal lipase activity, which
leads to decrease of lipid digestion and absorption in
intestine as hypolipidemic action [4].
The ACE plays a dominant role in the regulation of
the water electrolyte balance and blood pressure. Activa-
tion of this system has been considered to be a main
cause of renovascular hypertension [27,28]. The
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Figure 2 Effect of formulation Om3/terp on glucose (A) and oral starch tolerance test (B) in of control and experimental groups of
rats. Statistical analyses as given in Figure legend 1.
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Page 6 of 10physiological function of ACE is related to the regula-
tion of blood pressure and electrolyte homeostasis by
converting angiotensin I (Ang I) into potent vasocon-
strictor angiotensin II and by inactivating bradykinin
The importance of ACE inhibitors in the chronic treat-
ment of various cardiovascular diseases such as hyper-
tension, congestive heart failure, myocardial infarction,
diabetic nephropathy, or renal dysfunction is now well
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
0,02
0,04
0,06
0,08
0,1
0,12
0,14
Diab0 Con60 Diab60 Diab60
+For
Diab60
+FO
Diab60
+Om
Groups
T
o
t
a
l
 
n
-
3
 
f
a
t
t
y
 
a
c
i
d
s
 
(
m
g
/
g
)
 
*# 
*#@  
  *δ 
B 
*#@ δε 
0
0,02
0,04
0,06
0,08
0,1
0,12
0,14
Diab0 Con60 Diab60 Diab60
+For
Diab60
+FO
Diab60
+Om
Groups
T
o
t
a
l
 
n
-
3
 
f
a
t
t
y
 
a
c
i
d
s
 
(
m
g
/
m
L
)
 
*# 
*#@  
  *δ 
A 
*#@ δε 
Figure 3 Change in the plasma and liver omega fatty acids in diabetic rats treated with formulation Om3/terp. Statistical analyses as
given in Figure legend 1.
0
20
40
60
80
100
120
140
160
180
Diab0 Con60 Diab60 Diab60
+For
Diab60
+FO
Diab60
+Om
Groups
R
e
l
a
t
i
v
e
 
A
C
E
 
a
c
t
i
v
i
t
y
 
(
%
)
*# 
@  
*#@δ 
*#@ε 
Figure 5 Relative activity of ACE in plasma of control and experimental groups of rats. Statistical analyses as given in Figure legend 1.
Hamden et al. Lipids in Health and Disease 2011, 10:226
http://www.lipidworld.com/content/10/1/226
Page 7 of 10Table 2 Total cholesterol (TC), LDL-cholesterol (LDL-C), HDLcholesterol (HDL-C) and triglycerides (TG) in serum and
liver of diabetic rats treated with formulation Om3/terp.
Groups T-C HDL-C LDL-C TG
Serum (g/L)
Control 1.42 ± 0.12 0.63 ± 0.07 0.97 ± 0.05 0.57 ± 0.06
Diab 0day 1.87 ± 0.31* 0.57 ± 0.06* 1.30 ± 0.08* 0.98 ± 0.10*
Diab 60 day 2.61 ± 0.41
*# 0.41 ± 0.02
*# 2.20 ± 0.17
*# 1.54 ± 0.16
*#
Diab + For60 1.59 ± 0.21*
@ 0.78 ± 0.08*
#@ 1.13 ± 0.11*
#@ 0.74 ± 0.05*
#@
Control+ FO 2.18 ± 0.22*
@δ 0.54 ± 0.04*
@δ 1.76 ± 0.06*
#δ 0.61 ± 0.07
#@δ
Diab + Om60 1.86 ± 0.22*
@δε 0.83 ± 0.04*
#@ε 1.36 ± 0.06*
#δ 0.61 ± 0.07
#@δ
Liver (mg/g)
Control 1.1 ± 0.12 0.48 ± 0.03 0.62 ± 0.06 0.41 ± 0.06
Diab 0day 1.94 ± 0.21* 0.42 ± 0.03* 1.52 ± 0.17* 0.49 ± 0.05*
Diab 60 day 2.62 ± 0.30
*# 0.33 ± 0.05
*# 0.63 ± 0.07 0.89 ± 0.08
*#
Diab + For60 1.72 ± 0.31
*#@ 0.61 ± 0.05*
#@ 2.29 ± 0.29*
#@ 0.51 ± 0.06
@
Control+ FO 1.64 ± 0.10
#@δ 0.44 ± 0.07
@δ 0.30 ± 0.04*
#@δ 0.47 ± 0.05
@
Diab + Om60 1.24 ± 0.10
#@δ 0.65 ± 0.07*
#@ε 0.54 ± 0.04
#@δε 0.36 ± 0.05
#@δ
 
Con 
Diab + Om3 
Diab 
Diab + FO 
Figure 4 Effect of formulation Om3/terp administration to surviving diabetic rats on pancreas architecture.F i g u r e3p r e s e n t st h e
histopathological examination of pancreas. In control rat, the pancreas shows normal islets (Con). In alloxan-treated rats pancreas a severe b-
Cells atrophy was shown where the most pancreatic islets were completely empty after 8 weeks of alloxan administration (Diab day60). In
formulation Om3/terp treated diabetic rats; a patent protective action of b-Cells was shown and only initial stages of atrophy of b-Cells were
observed (Diab + For).
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Enalapril, Lisinopril and Temocapril are widely used in
the clinic for the treatment of hypertension. Moreover,
variations of serum ACE activity have been reported in
pathologies involving either a stimulation of monocyte
cell line or an endothelial abnormality [28]. This study
showed that diabetes was associated with increase of
plasma ACE activity and this activity was decreased sig-
nificantly by addition of formulation Om3/terp and this
action probably resulted to omega-3 fatty acids existing
in the fenugreek essential oil [12]. The important find-
ings in this study were that fenugreek essential oil has
an inhibitory effect on ACE. These result in accord with
the results of Balaraman et al [28] and Das [29,30],
where showed that administration of omega-3 fatty to
experimentally induced hypertension in rat reduced
blood pressure in fructose-induced hypertensive rats.
Thus, fenugreek seeds exhibit a significant antihyperten-
sive effect. The mechanism of action may partly involve
the serotonergic antagonistic property involving the 5-
HT2 receptor subtype.
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